Form 4: Ardent Health Director Acquires Restricted Stock Units

Peter J. Bulgarelli, a Director at Ardent Health, Inc., acquired 14,231 restricted stock units on April 1, 2026, as part of a compensation plan.

Summary

• Peter J. Bulgarelli, a Director at Ardent Health, Inc. (ARDT), acquired 14,231 shares of common stock on April 1, 2026.
• These shares were acquired as restricted stock units (RSUs) with a reported acquisition price of $0.
• The RSUs vest in full on the first anniversary of April 1, 2026, contingent upon Mr. Bulgarelli's continued service to the company.
• Following this transaction, Mr. Bulgarelli beneficially owns 14,231 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard compensation grant to a director rather than a significant strategic or financial event.

Positives

• Director Peter J. Bulgarelli's acquisition of restricted stock units indicates continued commitment and alignment with the company's long-term performance.
• The vesting schedule tied to continued service incentivizes the director to remain with Ardent Health, Inc.

Risks

• The value of the restricted stock units is subject to the company's future stock performance, meaning the ultimate benefit to the reporting person could fluctuate.
• Continued service is a condition for vesting, implying a risk of forfeiture if the reporting person's employment or directorship is terminated before the vesting date.

Future Outlook

The restricted stock units vest in full on the first anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through the vesting date.

Industry Context

StockSavvy.ai notes that insider transactions, particularly the acquisition of equity awards like restricted stock units by directors, are common in the healthcare services industry as a method to attract, retain, and incentivize key leadership aligned with long-term company value.

Stakeholder Impact

• Shareholders: The issuance of RSUs represents a form of compensation, which can dilute existing ownership over time if not matched by proportional value creation. However, it also aligns director interests with long-term shareholder value.
• Employees: This filing does not directly impact employees, but it reflects the company's compensation practices for its board members.
• Management: The transaction reinforces the company's strategy of using equity-based compensation to retain key leadership.

Next Steps

• Vesting of restricted stock units on the first anniversary of April 1, 2026, provided continued service.
• Continued monitoring of Peter J. Bulgarelli's beneficial ownership and any future transactions.

Key Dates

Keywords

Ardent Health, ARDT, Form 4, SEC Filing, Insider Transaction, Restricted Stock Units, Director Compensation, Beneficial Ownership